Julia founded Mila's Miracle Foundation in 2016 upon learning that her 6-yr-old daughter, Mila had Batten disease, a fatal genetic condition with no cure. In a race to save Mila, Julia’s collaboration with Dr. Tim Yu from Boston Children’s Hospital led to the first ever medicine designed for one person, named milasen. After initially halting Mila's symptoms, her disease slowly progressed, and in 2021, Mila died at just ten years old. Driven by a sense of hope and responsibility, Julia is on a mission to turn the groundbreaking work for Mila into an entirely new field of individualized medicines to help solve the global health crisis of genetic disease in children. In 2021, Julia co-founded EveryONE Medicines, the first biotech to meet the new era of individualized medicines, as well as the N=1 Collaborative, the international hub for this new paradigm. She has been leading the global movement, “Mila to Millions”, focused on convening the right people around the right ideas in the right places to pilot the regulatory and reimbursement change needed, as well as running an impact campaign on the moral imperative. She speaks regularly around the world, engaging academics, biotechs, governments and families alike.